Third Arc Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Lead T Cell Engager ARC101 to Treat CLDN6 Positive Cancers
— ARC101 is the company’s first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement — First-in-human... Read more.
Interplay Learning Launches Interplay Achieve for Education and Workforce Development Organizations
Interplay Achieve includes simulation-based courses and learning pathways for in-demand careers in the construction and industrial trades. AUSTIN, Texas, March... Read more.
PSP Investments joins CPP Investments and Ferrovial in 407 ETR ownership group
Transaction Highlights: PSP Investments to acquire significant minority stake of 7.51% in 407 ETR from CPP Investments CPP Investments and Ferrovial to concurrently... Read more.
AtkinsRéalis Reports Fourth Quarter 2024 Results; Introduces 2025 Outlook
Record-high Nuclear quarterly revenue and Segment Adjusted EBIT Strong positive operating cash flows Record-high AtkinsRéalis Services backlog MONTREAL, March 13,... Read more.
AtkinsRéalis Announces Renewal of Normal Course Issuer Bid
MONTREAL, March 13, 2025 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world,... Read more.
AtkinsRéalis Signs Agreements to Sell all of its Remaining 6.76% Interest in Highway 407 ETR to Ferrovial and CPP Investments for up to approximately $2.79 Billion
MONTREAL, March 13, 2025 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world,... Read more.
Yiren Digital to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
BEIJING, March 13, 2025 /PRNewswire/ — Yiren Digital Ltd. (NYSE: YRD) (“Yiren Digital”), an AI-powered platform providing a comprehensive suite... Read more.
THRIVE SCHOLARS ANNOUNCES GEORGE SPENCER AS CHIEF IMPACT OFFICER
LOS ANGELES, March 13, 2025 /PRNewswire/ — Thrive Scholars proudly welcomes George Spencer to its leadership team as Chief Impact Officer. A visionary strategist... Read more.
Strauss Group Announces Timing of Fourth Quarter & Full Year 2024 Earnings Release and Webcast
PETAH TIKVA, Israel, March 13, 2025 /PRNewswire/ — Strauss Group Ltd. (TASE: STRS), announces today that it will release its fourth quarter and full year... Read more.
Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak
WASHINGTON, March 13, 2025 /PRNewswire/ — The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially... Read more.